Partner Therapeutics
Latest round
- Series A
Last raised
- Feb 2018
Total raised
- $60M
Investors
- 3
About Partner Therapeutics
Partner Therapeutics, Inc.Founded in 2017 and headquartered in Boston, US, Partner Therapeutics specializes in biopharmaceutical products aimed at oncology and serious diseases.Partner Therapeutics (PTx) specializes in the development and commercialization of innovative biopharmaceutical products aimed at addressing unmet medical needs in oncology and other serious diseases. Their primary product offerings include BIZENGRI® (zenocutuzumab-zbco), which targets NRG1+ cancers, and LEUKINE® (sargramostim), designed to aid patients exposed to myelosuppressive radiation doses and improve outcomes in severe conditions such as sepsis. These products function by enhancing immune responses and promoting recovery from serious health conditions, thus serving a critical role in patient care.Partner Therapeutics generates revenue through the sale of its flagship products, BIZENGRI® and LEUKINE®, to healthcare providers and institutions, entering into direct supply agreements and partnerships that facilitate distribution. Revenue transactions typically occur in a Business-to-Business (B2B) model, where healthcare facilities procure these biopharmaceuticals either through direct purchase agreements or through wholesalers. Pricing structures for these products are tailored to reflect their therapeutic value and competitive positioning in the biochemical market, often negotiated between PTx and institutional buyers.Looking ahead, Partner Therapeutics aims to expand its product portfolio with upcoming therapies designed to address additional oncology indications. The company is also planning to enter new markets, focusing on regions in Europe and Asia by 2025.
Who invested in Partner Therapeutics
3 investors across 1 round
See all investors in Partner Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 1, 2018
Amount
$60M
Investors
Questions about Partner Therapeutics
Who invested in Partner Therapeutics?
Partner Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Partner Therapeutics raised?
Partner Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Partner Therapeutics last raise money?
Partner Therapeutics's most recent round on record is a Series A, in Feb 2018.
What does Partner Therapeutics do?
Partner Therapeutics is a pharmaceuticals company.
Where is Partner Therapeutics headquartered?
Partner Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Partner Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Partner Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Partner Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.